1. Guerrant, RL, et al. Practice guidelines for the management of infectious diarrhea. Clinical Infectious Diseases 2001; 32: 331–351.
2. Gaudreau, C, Gilbert, H. Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrobial Agents and Chemotherapy 2003; 47: 2027–2029.
3. Gupta, A, et al. Antimicrobial resistance among Campylobacter strains, United States, 1997–2001. Emerging Infectious Diseases 2004; 10: 1102–1109.
4. Lucey, B, et al. Trends in antimicrobial susceptibility among isolates of Campylobacter species in Ireland and the emergence of resistance to ciprofloxacin. Veterinary Record 2002; 151: 317–320.
5. Nachamkin, I, Ung, H, Li, M. Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA, 1982–2001. Emerging Infectious Diseases 2002; 8: 1501–1503.
6. Bodhidatta, L, et al. Bacterial enteric pathogens in children with acute dysentery in Thailand: increasing importance of quinolone-resistant Campylobacter. Southeast Asian Journal of Tropical Medicine and Public Health 2002; 33: 752–757.
7. Engberg, J, et al. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerging Infectious Diseases 2004; 10: 1056–1063.
8. Hakanen, A, et al. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. Emerging Infectious Diseases 2003; 9: 267–270.
9. Kassenborg, HD, et al. Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clinical Infectious Diseases 2004; 38 (Suppl. 3): S279–284.
10. Smith, KE, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992–1998. New England Journal of Medicine 1999; 340: 1525–1532.
15. Levy, SB. Antibacterial household products: cause for concern. Emerging Infectious Diseases 2001; 7: 512–515.
16. Black, RE, et al. Experimental Campylobacter jejuni infection in humans. Journal of Infectious Diseases 1988; 157: 472–479.
17. Blaser, MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. Journal of Infectious Diseases 1997; 176 (Suppl. 2): S103–105.
18. Greenland, S. Basic methods for sensitivity analysis and external adjustment. In: Rothman, KJ, Greenland, S eds. Modern Epidemiology. Philadelphia: Lippincott-Raven, 1998, pp. 343–355.
19. Gaudreau, C, Gilbert, H. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 1997; 39: 707–712.
20. Guevremont, E, et al. Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine, and chicken broilers. Canadian Journal of Veterinary Research 2006; 70: 81–86.
21. Gibreel, A, et al. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrobial Agents and Chemotherapy 2004; 48: 3442–3450.
22. Thwaites, RT, Frost, JA. Drug resistance in Campylobacter jejuni, C. coli, and C. lari isolated from humans in north west England and Wales, 1997. Journal of Clinical Pathology 1999; 52: 812–814.
23. Campylobacter Sentinel Surveillance Scheme Collaborators. Ciprofloxacin resistance in Campylobacter jejuni: case-case analysis as a tool for elucidating risks at home and abroad. Journal of Antimicrobial Chemotherapy 2002; 50: 561–568.
24. Gaunt, PN, Piddock, LJ. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. Journal of Antimicrobial Chemotherapy 1996; 37: 747–757.
25. Griggs, DJ, et al. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment. Antimicrobial Agents and Chemotherapy 2005; 49: 699–707.
26. McDermott, PF, et al. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. Journal of Infectious Diseases 2002; 185: 837–840.
27. Vanden, Eng J, et al. Consumer attitudes and use of antibiotics. Emerging Infectious Diseases 2003; 9: 1128–1135.
28. Carey, B, Cryan, B. Antibiotic misuse in the community – a contributor to resistance? Irish Medical Journal 2003; 96: 43–44, 46.
29. DuPont, HL. Travellers' diarrhoea: contemporary approaches to therapy and prevention. Drugs 2006; 66: 303–314.
30. McNulty, CA, et al. Antimicrobial drugs in the home, United Kingdom. Emerging Infectious Diseases 2006; 12: 1523–1526.
31. Reeves, DS, et al. Self-medication of antibacterials without prescription (also called ‘over-the-counter’ use). A report of a Working Party of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy 1999; 44: 163–177.
32. Pezzotti, G, et al. Occurrence and resistance to antibiotics of Campylobacter jejuni and Campylobacter coli in animals and meat in northeastern Italy. International Journal of Food Microbiology 2003; 82: 281–287.
33. Price, LB, et al. Fluoroquinolone-resistant Campylobacter isolates from conventional and antibiotic-free chicken products. Environmental Health Perspectives 2005; 113: 557–560.
34. Kos, VN, Keelan, M, Taylor, DE. Antimicrobial susceptibilities of Campylobacter jejuni isolates from poultry from Alberta, Canada. Antimicrobial Agents and Chemotherapy 2006; 50: 778–780.
36. Aubry-Damon, H, et al. Antimicrobial resistance in commensal flora of pig farmers. Emerging Infectious Diseases 2004; 10: 873–879.
37. Statistics and Data Development Unit. Employment in Alberta Agri-Food Industries, 2004, Alberta Agriculture, Food, and Rural Development; 2005 April, 7. Report No. 88.
38. Aiello, AE, Larson, E. Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infectious Diseases 2003; 3: 501–506.
39. Tan, L, et al. Use of antimicrobial agents in consumer products. Archives of Dermatology 2002; 138: 1082–1086.
40. Hartge, P. Participation in population studies. Epidemiology 2006; 17: 252–254.
41. Tam, CC, Rodrigues, LC, O'Brien, SJ. The study of infectious intestinal disease in England: what risk factors for presentation to general practice tell us about potential for selection bias in case-control studies of reported cases of diarrhoea. International Journal of Epidemiology 2003; 32: 99–105.